Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：101 Table Number：124
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Orphan Drug market in this environment. In terms of revenue, this research report indicated that the global Orphan Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Orphan Drug industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The AbbVie Inc. aims at producing XX Orphan Drug in 2020, with XX % production to take place in global market, Aegerion Pharmaceuticals, Inc. accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Orphan Drug Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Orphan Drug Market? AbbVie Inc. Aegerion Pharmaceuticals, Inc. Bristol-Myers Squibb Company Celgene Corporation F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc Johnson & Johnson Novartis AG Pfizer Inc. Sanofi ... Major Type of Orphan Drug Covered in XYZResearch report: Biologics Non-Biologics Application Segments Covered in XYZResearch Market Oncologic Diseases Metabolic Diseases Hematologic and Immunologic Diseases Infectious Diseases Neurologic Diseases Other Rare Diseases For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Orphan Drug Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Biologics -Product Introduction and Major Manufacturers 1.1.2 Non-Biologics -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Orphan Drug Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Orphan Drug Market 3.1.1 Top Companies leading Orphan Drug Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Orphan Drug Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Orphan Drug Market 3.2.1 Top Companies leading Orphan Drug Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Orphan Drug Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Orphan Drug Market 3.3.1 Top Companies leading Orphan Drug Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Orphan Drug Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Orphan Drug Market 3.4.1 Top Companies leading Orphan Drug Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Orphan Drug Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Orphan Drug Market 3.5.1 Top Companies leading Orphan Drug Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Orphan Drug Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Orphan Drug Market 3.6.1 Top Companies leading Orphan Drug Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Orphan Drug Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Orphan Drug Market 3.7.1 Top Companies leading Orphan Drug Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Orphan Drug Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Orphan Drug Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Orphan Drug Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Orphan Drug Sales and Growth Rate (2021-2026) 5.2 Global Orphan Drug Sales Value and Growth Rate (2021-2026) 6 Orphan Drug Competitive Analysis 6.1 AbbVie Inc. 6.1.1 AbbVie Inc. Company Profiles 6.1.2 AbbVie Inc. Product Introduction 6.1.3 AbbVie Inc. Orphan Drug Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Aegerion Pharmaceuticals, Inc. 6.2.1 Aegerion Pharmaceuticals, Inc. Company Profiles 6.2.2 Aegerion Pharmaceuticals, Inc. Product Introduction 6.2.3 Aegerion Pharmaceuticals, Inc. Orphan Drug Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Bristol-Myers Squibb Company 6.3.1 Bristol-Myers Squibb Company Company Profiles 6.3.2 Bristol-Myers Squibb Company Product Introduction 6.3.3 Bristol-Myers Squibb Company Orphan Drug Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Celgene Corporation 6.4.1 Celgene Corporation Company Profiles 6.4.2 Celgene Corporation Product Introduction 6.4.3 Celgene Corporation Orphan Drug Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 F. Hoffmann-La Roche Ltd. 6.5.1 F. Hoffmann-La Roche Ltd. Company Profiles 6.5.2 F. Hoffmann-La Roche Ltd. Product Introduction 6.5.3 F. Hoffmann-La Roche Ltd. Orphan Drug Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 GlaxoSmithKline plc 6.6.1 GlaxoSmithKline plc Company Profiles 6.6.2 GlaxoSmithKline plc Product Introduction 6.6.3 GlaxoSmithKline plc Orphan Drug Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Johnson & Johnson 6.7.1 Johnson & Johnson Company Profiles 6.7.2 Johnson & Johnson Product Introduction 6.7.3 Johnson & Johnson Orphan Drug Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Novartis AG 6.8.1 Novartis AG Company Profiles 6.8.2 Novartis AG Product Introduction 6.8.3 Novartis AG Orphan Drug Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Pfizer Inc. 6.9.1 Pfizer Inc. Company Profiles 6.9.2 Pfizer Inc. Product Introduction 6.9.3 Pfizer Inc. Orphan Drug Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 Sanofi 6.10.1 Sanofi Company Profiles 6.10.2 Sanofi Product Introduction 6.10.3 Sanofi Orphan Drug Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Orphan Drug Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Orphan Drug Sales (K Unit) by Type (2015-2026) Figure Global Orphan Drug Sales (K Unit) and Growth Rate (2015-2026) Figure Global Orphan Drug Sales Market Share (%) by Type (2019 -2020) Table Global Orphan Drug Sales Value (Million USD) by Type (2015-2026) Figure Global Orphan Drug Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Orphan Drug Sales Value Market Share (%) by Type (2019-2020) Table Global Orphan Drug Sales (K Unit) by Application (2015-2026) Table China Orphan Drug Sales (K Unit) of Major Company (2015-2020) Table China Orphan Drug Sales Market Share of Major Company (2015-2020) Table China Orphan Drug Sales Value (Million USD) of Major Company (2015-2020) Figure China Orphan Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table China Orphan Drug Sales Value Share of Major Company (2015-2020) Table China Orphan Drug Price (USD/Unit), by Type (2019-2020) Table China Orphan Drug Sales (Unit) by Type (2015-2026) Figure China Orphan Drug Sales (Unit) by Type (2015-2026) Table EU Orphan Drug Sales (K Unit) of Major Company (2015-2020) Table EU Orphan Drug Sales Market Share of Major Company (2015-2020) Table EU Orphan Drug Sales Value (Million USD) of Major Company (2015-2020) Figure EU Orphan Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Orphan Drug Sales Value Share of Major Company (2015-2020) Table EU Orphan Drug Price (USD/Unit), by Type (2019-2020) Table EU Orphan Drug Sales (Unit) by Type (2015-2026) Figure EU Orphan Drug Sales (Unit) by Type (2015-2026) Table USA Orphan Drug Sales (K Unit) of Major Company (2015-2020) Table USA Orphan Drug Sales Market Share of Major Company (2015-2020) Table USA Orphan Drug Sales Value (Million USD) of Major Company (2015-2020) Figure USA Orphan Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Orphan Drug Sales Value Share of Major Company (2015-2020) Table USA Orphan Drug Price (USD/Unit), by Type (2019-2020) Table USA Orphan Drug Sales (Unit) by Type (2015-2026) Figure USA Orphan Drug Sales (Unit) by Type (2015-2026) Table Japan Orphan Drug Sales (K Unit) of Major Company (2015-2020) Table Japan Orphan Drug Sales Market Share of Major Company (2015-2020) Table Japan Orphan Drug Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Orphan Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Orphan Drug Sales Value Share of Major Company (2015-2020) Table Japan Orphan Drug Price (USD/Unit), by Type (2019-2020) Table Japan Orphan Drug Sales (Unit) by Type (2015-2026) Figure Japan Orphan Drug Sales (Unit) by Type (2015-2026) Table India Orphan Drug Sales (K Unit) of Major Company (2015-2020) Table India Orphan Drug Sales Market Share of Major Company (2015-2020) Table India Orphan Drug Sales Value (Million USD) of Major Company (2015-2020) Figure India Orphan Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table India Orphan Drug Sales Value Share of Major Company (2015-2020) Table India Orphan Drug Price (USD/Unit), by Type (2019-2020) Table India Orphan Drug Sales (Unit) by Type (2015-2026) Figure India Orphan Drug Sales (Unit) by Type (2015-2026) Table Southeast Asia Orphan Drug Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Orphan Drug Sales Market Share of Major Company (2015-2020) Table Southeast Asia Orphan Drug Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Orphan Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Orphan Drug Sales Value Share of Major Company (2015-2020) Table Southeast Asia Orphan Drug Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Orphan Drug Sales (Unit) by Type (2015-2026) Figure Southeast Asia Orphan Drug Sales (Unit) by Type (2015-2026) Table South America Orphan Drug Sales (K Unit) of Major Company (2015-2020) Table South America Orphan Drug Sales Market Share of Major Company (2015-2020) Table South America Orphan Drug Sales Value (Million USD) of Major Company (2015-2020) Figure South America Orphan Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Orphan Drug Sales Value Share of Major Company (2015-2020) Table South America Orphan Drug Price (USD/Unit), by Type (2019-2020) Table South America Orphan Drug Sales (Unit) by Type (2015-2026) Figure South America Orphan Drug Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Orphan Drug Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Orphan Drug Figure Cost Structure of Orphan Drug in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Orphan Drug Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Orphan Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table AbbVie Inc. Profiles Table AbbVie Inc. Orphan Drug Product Introduction Table AbbVie Inc. Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure AbbVie Inc. SWOT Analysis Table Aegerion Pharmaceuticals, Inc. Profiles Table Aegerion Pharmaceuticals, Inc. Orphan Drug Product Introduction Table Aegerion Pharmaceuticals, Inc. Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Aegerion Pharmaceuticals, Inc. SWOT Analysis Table Bristol-Myers Squibb Company Profiles Table Bristol-Myers Squibb Company Orphan Drug Product Introduction Table Bristol-Myers Squibb Company Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Bristol-Myers Squibb Company SWOT Analysis Table Celgene Corporation Profiles Table Celgene Corporation Orphan Drug Product Introduction Table Celgene Corporation Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Celgene Corporation SWOT Analysis Table F. Hoffmann-La Roche Ltd. Profiles Table F. Hoffmann-La Roche Ltd. Orphan Drug Product Introduction Table F. Hoffmann-La Roche Ltd. Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure F. Hoffmann-La Roche Ltd. SWOT Analysis Table GlaxoSmithKline plc Profiles Table GlaxoSmithKline plc Orphan Drug Product Introduction Table GlaxoSmithKline plc Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure GlaxoSmithKline plc SWOT Analysis Table Johnson & Johnson Profiles Table Johnson & Johnson Orphan Drug Product Introduction Table Johnson & Johnson Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Johnson & Johnson SWOT Analysis Table Novartis AG Profiles Table Novartis AG Orphan Drug Product Introduction Table Novartis AG Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Novartis AG SWOT Analysis Table Pfizer Inc. Profiles Table Pfizer Inc. Orphan Drug Product Introduction Table Pfizer Inc. Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Pfizer Inc. SWOT Analysis Table Sanofi Profiles Table Sanofi Orphan Drug Product Introduction Table Sanofi Orphan Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
